Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LEXICON PHARMACEUTICALS, INC. | VP, Chief Commercial Officer | Common Stock | 53.1K | $56K | $1.05 | Feb 28, 2023 | Direct |
LEXICON PHARMACEUTICALS, INC. | VP, Chief Commercial Officer | Restricted Stock Units | 45.9K | $48.4K | $1.05 | Feb 28, 2023 | Direct |
LEXICON PHARMACEUTICALS, INC. | VP, Chief Commercial Officer | Stock Option (Right to Buy) | 280K | Feb 9, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LXRX | LEXICON PHARMACEUTICALS, INC. | Feb 28, 2023 | 7 | -$25.6K | 4 | Mar 1, 2023 | VP, Chief Commercial Officer |
LXRX | LEXICON PHARMACEUTICALS, INC. | Feb 9, 2023 | 2 | $0 | 4 | Feb 13, 2023 | VP, Chief Commercial Officer |
LXRX | LEXICON PHARMACEUTICALS, INC. | Feb 28, 2022 | 7 | -$23.5K | 4 | Feb 28, 2022 | VP, Chief Commercial Officer |
LXRX | LEXICON PHARMACEUTICALS, INC. | Feb 10, 2022 | 2 | $0 | 4 | Feb 14, 2022 | VP, Chief Commercial Officer |
LXRX | LEXICON PHARMACEUTICALS, INC. | Oct 28, 2021 | 0 | $0 | 3 | Oct 29, 2021 | VP, Chief Commercial Officer |